-+ 0.00%
-+ 0.00%
-+ 0.00%

Disc Medicine To Present Data From Multiple Clinical Programs At The SOHO Annual Meeting, To Be Held In Houston, Texas, On September 9-12, 2026

Benzinga·08/31/2026 22:02:59
Listen to the news

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from multiple clinical programs, including an oral presentation of initial data from the RESTORE-PV trial of DISC-3405 in patients with polycythemia vera (PV), at the SOHO Annual Meeting, which will be held in Houston, Texas on September 9-12, 2026.